Valuation Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq Other stock markets 04:00:00 24/06/2026 HKT			5-day change	1st Jan Change
468.42 ^USD	+0.35%		+3.99%	+3.32%

06-22	Proteome contract win; Eco Buildings milestone	AN
06-18	Vertex Pharmaceuticals Insider Sold Shares Worth $1,827,900, According to a Recent SEC Filing	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	118,474	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	3%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	105,689	101,340	96,972
Change	-	31.13%	47.8%	4.23%	11.09%	-2.52%	-4.12%	-4.31%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	26.8x	23.8x	20.3x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	5.37x	4.48x	3.78x
PEG	-	0.5x	3.51x	2x	-0x	1.9x	1.9x	1.2x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	9.09x	8.3x	7.48x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	8.11x	7.1x	6.12x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	18.3x	15.2x	12.7x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	19x	16x	13.2x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	21.8x	19.7x	17.2x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	4.59%	5.07%	5.82%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	17.49	19.71	23.03
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,038	14,267	15,840
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	5,782	6,651	7,618
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,554	6,319	7,333
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,451	5,053	5,979
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-12,785	-17,134	-21,501
Reference price ²	219.60	288.78	406.89	402.70	453.36	468.42	468.42	468.42
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,805	-	-
Announcement Date	26/1/22	7/2/23	5/2/24	10/2/25	12/2/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	26.69x	8.11x	18.28x	-.--%	118B
ELI LILLY AND COMPANY	32.11x	11.73x	24.06x	0.62%	983B
JOHNSON & JOHNSON	24.72x	5.7x	15.5x	2.31%	557B
ABBVIE INC.	28.55x	6.84x	14.01x	3.01%	406B
ROCHE HOLDING AG	16.98x	4.23x	10.4x	3.14%	314B
ASTRAZENECA PLC	22.08x	4.62x	13.09x	1.89%	273B
NOVARTIS AG	20.6x	5.34x	12.96x	3.01%	272B
NOVO NORDISK A/S	13.31x	4.94x	10.16x	3.78%	203B
AMGEN INC.	22.41x	6.02x	10.5x	2.93%	186B
GILEAD SCIENCES, INC.	-44.74x	5.4x	29.79x	2.6%	155B
Average	16.27x	6.29x	15.88x	2.33%	346.88B
Weighted average by Cap.	22.20x	7.34x	17.05x	2.06%